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Purpose: Epidermolysis bullosa (EB) is associated with variable risks of extracu-
taneous manifestations and death. Currently, there is limited information on the 
clinical course and prognosis of EB in Korea. This study analyzed the nutritional 
outcomes, clinical morbidity, and mortality of children with EB. Materials and 
Methods: Thirty patients, admitted to Severance Hospital and Gangnam Sever-
ance Hospital, from January 2001 to December 2011, were retrospectively en-
rolled. All patients were diagnosed with EB classified by dermatologists. Results: 
Among the 30 patients, 5 patients were diagnosed with EB simplex, four with 
junctional EB, and 21 with dystrophic EB. Wound infection occurred in 47% of 
the patients, and blood culture-proven sepsis was noted in 10% of the patients. 
Two (9.2%) patients had esophageal stricture and 11 (52.4%) of the dystrophic EB 
patients received reconstructive surgery due to distal extremity contracture. There 
were five mortalities caused by sepsis, failure to thrive, and severe metabolic aci-
dosis with dehydration. According to nutrition and growth status, most of the in-
fants (97%) were born as appropriate for gestational age. However, at last follow-
up, 56% of the children were below the 3rd percentile in weight, and 50% were 
below the 3rd percentile in weight for height. Sixty percent of the children had a 
thrive index below -3. Conclusion: Postnatal growth failure is a serious problem 
in children with EB. Strategies to maximize nutritional support could alleviate 
growth failure in children with EB, and thus improve clinical outcomes.
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INTRODUCTION
Epidermolysis bullosa (EB), inherited as an autosomal dominant or recessive dis-
order, is characterized by blister formation and erosion of the skin and mucous 
membranes with minor trauma.1 Based on histologic involvement, there are three 
major EB classifications: EB simplex (EBS), junctional EB (JEB), and dystrophic 
EB (EBD).2,3 EB simplex occurs within basal keratinocytes, and shows the mildest 
clinical manifestations. JEB involves the lamina lucida; the Herlitz subtype of JEB 
causes the most severe phenotype, consisting of intractable erosion blisters, and 
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tional indices as weight, weight for height, and thrive index. 
Percentile of weight and weight for height were calculated 
based on the 2007 Korean national growth charts.10 The 
thrive index was calculated based on the same growth stan-
dards, using the following formula: weight standard devia-
tion-(birth weight standard deviation×0.4).10,11 We also col-
lected histologic classification, clinical history, and laboratory 
findings for each patient. Medical records as well as inpa-
tient and outpatient charts, laboratory results, pathology re-
sults, and skeletal radiographs of all affected patients were 
reviewed.
 
RESULTS
 
Among 30 cases of EB, 17 cases (57%) were male and 13 
cases (43%) were female. All of the patients showed skin 
symptoms at birth. Subtype analysis identified 5 cases of 
EBS (17%), 4 cases of JEB (13%), and 21 cases of EBD 
(70%). All were born at term gestation. Twenty-nine (97%) 
of the patients were appropriate for gestational age; one case 
of EB simplex was small for gestational age. Among EBS, 
EBD, and JEB groups, there were no significant differences 
in gestation and birth weight (p=0.35, p=0.09) (Table 1).
Nutritional status based on growth parameters is shown 
in Table 2. At last follow-up, fifty-six percent of the patients 
were below the 3rd percentile in weight. In regards to weight 
for height, 50% were below the 3rd percentile. Among the 
EBS, JEB, and EBD patients, the proportions of patients 
below the 3rd percentile in weight and weight for height 
were not different between the subgroups. Eighteen patients 
(60%) were below -3 on the thrive index. There was no sig-
nificant difference in the number of those below -3 on the 
thrive index among EB subtypes. The most recent follow-
up indicated that most of the patients were below the 3rd 
percentile in weight, weight for height, and thrive index, re-
flecting a failure to thrive (Table 2). 
progresses to an early death due to infection. Dystrophic 
EB occurs in the dermis and manifests as blistering, scar-
ring, and milia formation.3,4
According to the US national EB registry, the estimated 
prevalence of EB in the United States was 8.22 per 1 mil-
lion individuals in 2008.5 The Australian registry reported 
an estimated prevalence rate of 10.3 cases per million in 
2009.6 The epidemiology of EB in Korea has not been re-
ported; only one study reported a prevalence of about 68 
EB cases in 1993.7
Because multiple organ system involvement occurs early in 
EB patients, clinicians should carefully evaluate conditions 
such as dental manifestations, gastrointestinal tract involve-
ment, infection, and musculoskeletal problems.3,8 Severe fail-
ure to thrive, as a consequence of restricted nutritional intake, 
and chronic constipation have been reported as the main 
causes of death in EB patients.8,9 Therefore, aggressive nu-
tritional support to prevent growth failure, nutritional defi-
ciencies, and compromised immunity may affect disease 
outcome. Unfortunately, information concerning the clini-
cal course and prognosis of EB is very limited in Korea. 
Accordingly, this study was designed to analyze the nutri-
tional outcomes, clinical morbidity, and mortality of chil-
dren with EB in Korea.
MATERIALS AND METHODS
　　　
We retrospectively analyzed 38 patients with EB. The pa-
tients were diagnosed by dermatologists at Severance Hos-
pital and Gangnam Severance Hospital using immunofluo-
rescence, mapping, and transmission electron microscopy 
from January 2001 to December 2011. Eight patients were 
excluded because of a lack of information. Data concerning 
height and weight at birth and at the last follow-up (median 
60.5, range 1-224 month) were collected, and each patient’s 
percentile in growth was determined. We designated nutri-
Table 1. Clinical Characteristics in Children with EB
EBS (5) JEB (4) EBD (21) Total (30)
Sex (M : F) 1 : 0.4 1 : 0.3 1 : 1.1 1 : 0.9
NSVD/C-sec 3/2 2/2 10/11 15/15
Gestational age (wks) 38.2±1.2 39.3±2.2 38.6±2.1 38.7±1.9
Birth weight (kg)   3.10±0.56   3.45±1.01   3.35±0.87   3.31±0.95
AGA 4 4 21 29
SGA 1 0   0   1
NSVD, normal spontaneous vaginal delivery; C-sec, cesarean section; SGA, small for gestational age; EBS, epidermolysis bullosa simplex; JEB, junctional 
epidermolysis bullosa; EBD, dystrophic epidermolysis bullosa; AGA, appropriate for gestational age; EB, epidermolysis bullosa.
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es, sepsis in 2 cases, and severe acidosis with dehydration in 
one case. Among mortality cases, 4 patients were below the 
3rd percentile of weight and weight for height, and one was 
below the 5th percentile of weight and weight for height at 
the time of death. A skin wound site and blood culture were 
performed. Methicillin-resistant Staphylococcus aureus was 
confirmed as the primary cultured organism at the wound 
site. Pseudomonas aeruginosa, Staphylococcus hominis, and 
candida were cultured in the blood. Twelve patients under-
went reconstructive plastic surgery operations for leg and 
hand contracture, and 11 of the patients had EBD. Two pa-
tients with EBD experienced esophageal stricture treated 
with esophageal ballooning, and all of the patients required 
dental care to address gum problems (Table 3).
Weight SD scores at birth and thrive index scores at last 
follow-up are shown in Fig. 1, and reflect overall growth fail-
Serum albumin (median 2.7 g/dL range 1.8-3.5 g/dL) and 
serum protein (median 5.9 g/dL, range 4.8-7.0 g/dL) levels 
were recorded as their lowest values. Ten (33%) patients 
demonstrated a hypoalbuminemia event (<2.5 g/dL) during 
evaluation; all mortality cases-showed marked hypoalbu-
minemia. The median cholesterol level was 148 mg/dL and 
ranged from 120-187 mg/dL. Aspartate aminotransferase 
and alanine aminotransferase levels did not reveal any spe-
cific findings. Serum protein, albumin, and cholesterol lev-
els tended to be at the lower margin of normal values. 
According to morbidity and mortality survey, there were 
five patient deaths. The median age at time of death was 7.3 
months (15 day-22 month). Three deaths (60%) were noted 
in children with JEB, one with EBS, and another with EBD. 
A mortality rate of up to 75% was noted in patients with 
JEB. The causes of death included failure to thrive in 2 cas-
Table 2. Nutrition and Growth Outcomes in Children with EB
EBS (5) JEB (4) EBD (21) Total (30)
Last F/U (month)* 28.3 (1-71) 11.3 (2-24)  72 (11-224) 60.5 (1-224)
Weight, % (n)
    <3 p 40 (2) 75 (3) 57 (12) 56 (17)
    3-10 p 20 (1) 25 (1) 27 (6) 27 (8)
    10-25 p 20 (1)   0 10 (2) 10 (3)
    25-50 p   0   0   0   0
    50-75 p 20 (1)   0   5 (1)   6 (2)
Weight for height, % (n)
    <3 p 80 (4) 50 (2) 43 (9) 50 (15)
    3-10 p   0 50 (2) 37 (8) 33 (10)
    10-25 p 20 (1)   0 10 (2) 13 (4)
    25-50 p   0   0   5 (1)   3 (1)
    50-75 p   0   0   5 (1)   3 (1)
Thrive index, % (n)†
    <-3 60 (3) 75 (3) 66 (14) 60 (18)
    -3 - -2 20 (1) 25 (1) 19 (4) 20 (6)
    -2 - -1 20 (1)   5 (1)   6 (2)
    -1-0   5 (1)   3 (1)
EBS, epidermolysis bullosa simplex; JEB, junctional epidermolysis bullosa; EBD, dystrophic epidermolysis bullosa; p, percentile; EB, epidermolysis bullosa.
*Median (range).
†Thrive index: later weight SD-(birth weight SD×0.4).
Table 3. Clinical Morbidity and Mortality in Children with EB
EBS (5) JEB (4) EBD (21) Total (30)
Mortality 1 (20%) 3 (75%)   1 (4.8%)   5 (17%) 
Infection 
    Skin 3 (60%) 3 (75%)   8 (38.1%) 14 (47%) 
    Sepsis 1 (20%) 2 (50%)   0   3 (10%) 
Reconstruction operation 1 (20%) 0 11 (52.4%) 12 (40%) 
Esophageal stricture 0 0   2 (9.2%)   2 (7%) 
Dental problems 2 (40%) 2 (50%)   8 (38.1%) 12 (40%) 
EBS, epidermolysis bullosa simplex; JEB, junctional epidermolysis bullosa; EBD, dystrophic epidermolysis bullosa; EB, epidermolysis bullosa.
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study, although 40% of the patients developed skin infec-
tions, only 10% of the cases involved blood culture-proven 
sepsis.
In general, infant mortality reports of sepsis by the age of 1 
year have ranged from 0.4% to 19.5%. By age 15, the cumu-
lative risk of death from sepsis increased to 24.2% for EB pa-
tients.15 In our study, sepsis was the main cause of death, and 
was responsible for 40% of patient mortalities. Additionally, 
we discerned that severe failure to thrive caused by pro-
longed hospitalization and repeated loss of blood constitu-
ents from the skin could lead to secondary immunosuppres-
sion, predisposing the patient to infection. In our study, 
prolonged hospitalization (median 41 days, range 14-290 
days) was noted.
Death from failure to thrive is also a major concern, pri-
marily in JEB.16 The cumulative and conditional risks of 
failure to thrive ranges from 40% to 44.7% by age 1, and 
rises to 61.8% with JEB by age 15. Sepsis, failure to thrive, 
and respiratory failure were the major causes of death in 
children with JEB, although these conditions plateaued by 
age 2 to 6.16 The Dutch EB Registry reported that, between 
1988 and 2011, the average age at death was 5.8 months for 
22 JEB-Herlitz type patients. These deaths were caused by, 
in order of prevalence, failure to thrive, respiratory failure, 
pneumonia, dehydration, anemia, sepsis, and euthanasia.17 
Invasive treatments to extend life did not promote survival, 
ure in EB patients. Especially, across the whole range of birth 
weights, patients identified with infections tended to show 
lower thrive index scores at last follow-up, compared to the 
patients noninfected patients, reflecting severe growth fail-
ure; nevertheless, this was not statistically different (p=0.08). 
DISCUSSION
The present study is the first in Korea to investigate detailed 
growth and nutritional outcomes in children with EB. Pre-
viously, only one report has assessed the risks of complica-
tions related to EB in Korea. Little information is available 
regarding the natural history and nutritional analysis of 
each major EB subtype in Korea. 
EB is an inherited mechanobullous disorder character-
ized by skin fragility and blister formation.12 To date, over 
1000 different mutations involving 14 structural genes with-
in the skin have been shown to be associated with EB clini-
cal phenotype.5,13 EB is associated with many clinically dis-
tinctive phenotypes, all of which consist of skin blistering 
as a major feature, which may vary in regards to the degree 
of extracutaneous manifestations and death.5 Previously, 
manifestations of external eye erosion, esophageal stricture, 
intestinal malabsorption, hydronephrosis, and chronic renal 
failure have been reported. Additionally, severe complica-
tions in the musculoskeletal system, heart, bone marrow, 
and oral cavity (enamel hypoplasia, microstomia, and anky-
loglossia) have been reported to contribute to morbidity and 
even death.
The prevalence of EB has not yet been reported in Korea. 
In 1986 the National Institutes of Health established the 
National Epidermolysis Bullosa Registry to determine the 
risk of extracutaneous outcomes.8 Over 16 years, 3280 pa-
tients throughout the United States were enrolled and eval-
uated. The Australian Epidermolysis Bullosa Registry was 
established in 2006, and has continued to increase in size 
and profile locally. In the United Kingdom, 2930 patients 
have been enrolled for over 16 years of follow up with the 
National EB Registry since 1993.6
In the past, infant mortality from infection was a major 
concern due to the unavailability of sophisticated wound 
care products, the lack of burn unit technique applications, 
and the absence or incorrect use of broad-spectrum topical 
and systemic antibiotics.14 Over the past 20 years, however, 
various synthetic dressings have been developed and are 
used extensively in daily care for patients with EB. In our 
Fig. 1. For children with EB, thrive index at last follow-up plotted against 
weight standard at birth, reflecting poor weight gain as a negative index. 
Thrive index was not related to weight standard deviation score (SDS) at 
birth, and was not different between infection and non-infection sub-
groups. Black circles indicate EB patients with infection and open circles 
represent those without infection. EB, epidermolysis bullosa. 
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This study had some limitations due to the small number 
of subjects recruited from only two institutions. Nutritional 
and clinical outcomes among EB subtypes were not differ-
ent, which possibly may be related to small numbers in the 
EB subgroups. Because our population was not a nation-
wide registry, it may not reflect the overall outcomes of 
EBD in Korea. Therefore, it will be important to establish a 
national EB registry. 
In conclusion, this is the first study to evaluate the growth 
and clinical outcomes of children with EB in Korea. Al-
though sepsis developed in a relatively low number of pa-
tients, growth failure was a serious problem, possibly related 
to nutritional deficiencies. Strategies to maximize nutrition 
and growth status may affect outcomes for children with EB. 
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